[1] Qiao YC, Xu Y, Jiang DX, et al. Epidemiological analyses of regional and age differences of HIV/AIDS prevalence in China, 2004–2016. Int J Infect Dis, 2019; 81, 215−20. doi:  10.1016/j.ijid.2019.02.016
[2] Wu ZY, Chen JF, Scott SR, et al. History of the HIV epidemic in China. Curr HIV/AIDS Rep, 2019; 16, 458−66. doi:  10.1007/s11904-019-00471-4
[3] Brown T, Peerapatanapokin W. The Asian Epidemic Model: a process model for exploring HIV policy and programme alternatives in Asia. Sex Transm Infect, 2004; 80, i19−24. doi:  10.1136/sti.2004.010165
[4] Liu L, Luan RS, Yang W, et al. Projecting dynamic trends for HIV/AIDS in a highly endemic area of China: estimation models for Liangshan Prefecture, Sichuan Province. Curr HIV Res, 2009; 7, 390−7. doi:  10.2174/157016209788680642
[5] Liu S, Wang QX, Nan L, et al. The changing trends of HIV/AIDS in an ethnic minority region of China: modeling the epidemic in Liangshan prefecture, Sichuan Province. Biomed Environ Sci, 2013; 26, 562−70.
[6] Cohen J. The Asian epidemic model's provocative curves. Science, 2004; 304, 1934. doi:  10.1126/science.304.5679.1934
[7] Zule WA, Bobashev G. High dead-space syringes and the risk of HIV and HCV infection among injecting drug users. Drug Alcohol Depend, 2009; 100, 204−13. doi:  10.1016/j.drugalcdep.2008.08.017
[8] Lu F, Wang N, Wu Z, et al. Estimating the number of people at risk for and living with HIV in China in 2005: methods and results. Sex Transm Infect, 2006; 82 Suppl 3, iii87-91.
[9] Zhao M, Ling W. HIV/AIDS and drug use in China—interactions, impacts, and issues. Subst Use Misuse, 2012; 47, 1015−25. doi:  10.3109/10826084.2012.663284
[10] Hu Y, Liu L, Luo YJ, et al. The HIV epidemic situation of students in Sichuan Province. J Prev Med Inf, 2016; 32, 1337−40. (In Chinese
[11] Cao BL, Liu CC, Durvasula M, et al. Social media engagement and HIV testing among men who have sex with men in China: a nationwide cross-sectional survey. J Med Internet Res, 2017; 19, e251. doi:  10.2196/jmir.7251
[12] Yang H, Li YP, Xu MJ, et al. The update of HIV-1 prevalence and incidence and spatio-temporal analyses of HIV recent infection among four sub-groups in Sichuan, China during surveillance period between 2016 and 2022. Infect Drug Resist, 2023; 16, 6535−48. doi:  10.2147/IDR.S428744
[13] Ma GY, Chen HY, Chen J. Cohort study on the transmission of human immunodeficiency virus between spouses. J Public Health Prev Med, 2013; 24, 54−6. (In Chinese
[14] Hugonnet S, Mosha F, Todd J, et al. Incidence of HIV infection in stable sexual partnerships: a retrospective cohort study of 1802 couples in Mwanza Region, Tanzania. JAIDS J Acquir Immune Defic Syndr, 2002; 30, 73−80. doi:  10.1097/00042560-200205010-00010
[15] Li HR, Wang Z, Yang L. Risk factors associated with HIV transmission between spouses in Henan. Chin J AIDS STD, 2008; 14, 39−41. (In Chinese
[16] Zeng YL, Tan Y, Yang W, et al. Analyzing the status of follow-up management on HIV/AIDS cases in a minority region of Sichuan. Chin Health Ser Manag, 2017; 34, 472−3,480. (In Chinese
[17] Yu HF, Han Y, Shi YH, et al. Case-control study of the correlation of partner notification and HIV testing with seroconversion of spouses among human immunodeficiency virus sero-discordant couples. Chin J AIDS STD, 2017; 23, 898−900,908. (In Chinese
[18] Yang Y, Luan RS, Liu P, et al. Casual sex and concurrent sexual partnerships among young people from an Yi community with a high prevalence of HIV in China. Asian J Androl, 2012; 14, 758−65. doi:  10.1038/aja.2012.25
[19] Deng L, Liu ZF, Zhang SZ, et al. Survival time and related influencing factors of AIDS patients in Liangshan prefecture, Sichuan province, during 2008-2013. Chin J Epidemiol, 2015; 36, 569−75. (In Chinese
[20] Chen SM, Lin YN, He XH, et al. Clinical trial and safety of highly active antiretroviral therapy in the treatment of human immunodeficiency virus patients. Chin J Clin Pharmacol, 2017; 33, 1618−20. (In Chinese